Financial toxicity experienced by patients with breast cancer-related lymphedema: a systematic review

Financial Toxicity Associated With Cleft Palate Repair: A Survey of Family Financial Well-Being

BACKGROUND

Financial toxicity refers to the economic burden of treatment on patients, families, and caregivers of those with chronic medical conditions. The authors sought to add to the literature regarding the financial burden on families with children undergoing cleft palate reconstruction.

METHODS

A survey assessing income, debt, and other indicators of financial impact, such as out-of-pocket (out of pocket) costs, was sent to the parents of patients who had cleft palate repair at age 18 or younger identified through CPT codes from the authors' institution's electronic medical record.

RESULTS

One hundred eighty-six began the survey; however, only 64 (9%) respondents completed the survey and were included in the statistical analysis. The average total out-of-pocket cost was $45,140 (range: $0-$400,000). Eleven respondents (17%) reported that their debt balance had increased after treatment, whereas only 3 respondents (5%) reported an improvement in their debt. However, there was no significant association between increased debt balance and increased out-of-pocket costs. Twenty-five respondents (39%) reported a reduction in their working hours. Over half (53%) reported that they and their partner missed more than 3 weeks of work cumulatively throughout their child's treatment. Thirty respondents (47%) reported a reduction in essential household expenses and 40 respondents (63%) reported a reduction in non-essential spending.

CONCLUSIONS

Costs associated with cleft palate care results in significant financial toxicity for families of children with cleft palate. Pending legislation, including the Ensuring Lasting Smiles Act, could ameliorate out-of-pocket costs and reduce financial toxicity for cleft patients and their families.

Cancer-related financial toxicity among Latinas with breast cancer in a rural area of the United States: a qualitative study

BACKGROUND

Financial toxicity, or the adverse impact of cancer diagnoses on survivors' financial well-being, is an increasing global concern. In the United States, it is disproportionately high among racial/ethnic minorities. Latina breast cancer patients encounter greater financial burdens than their non-Latina White counterparts, which can lead to discontinuation of medical treatment, poor quality of life, or early mortality. In particular, cancer patients in rural regions are at a greater risk for financial toxicity due to a lack of resources and structural barriers. Despite its magnitude, financial toxicity among Latina breast cancer patients who reside in rural areas is understudied. This study aims to fill this gap by exploring financial toxicity from the perspectives of Latina breast cancer patients, family members, and healthcare professionals.

METHODS

This qualitative, cross-sectional study aimed to address this gap in the literature through in-depth interviews with 47 participants, including Latina breast cancer patients (n = 21), their family members/caregivers (n = 14), and healthcare professionals (n = 12), all from a rural agricultural region, with a focus on contributing factors and impacts of financial toxicity. Qualitative data were analyzed using a thematic analysis approach. Demographic data were analyzed using descriptive statistics.

RESULTS

The main themes relating to contributions to changes in patient financial situations included (1) employment disruption (e.g., reduced working hours and quitting the job) post breast cancer diagnosis, and (2) medical-related (out-of-pocket costs, co-payment) and non-medical related financial costs (transportation, childcare). The impacts of financial toxicity were multi-faceted. Patients struggled to meet basic needs (e.g., food, paying bills) and experienced psychological distress. Coordinating patient support care (e.g., transportation, caretaking) to accommodate their financial needs negatively impacted their families' work schedules and routines. It also affected family relationships, leading to family conflicts, including marital conflict, as well as patients' continuum of cancer care.

CONCLUSIONS

Financial toxicity encountered by rural Latina breast cancer patients is complex, and its adverse effects are multifaceted. Culturally appropriate interventions targeting patients and families to address their personal, psychological, and familial issues related to financial toxicity are needed.

"Do I buy my children shoes, or do I get a compression garment for my lymphoedema?" Australian stakeholder perspectives on cancer-related lymphoedema care

PURPOSE

To identify the experiences and challenges some cancer survivors face in managing lymphoedema and to explore how they and healthcare professionals can best address them.

METHODS

A qualitative participatory methodology was employed, involving two stakeholder consultation workshops (one face-to-face and one online). Sessions were audio-recorded, and thematically analysed. Workshops involved 55 participants, comprising people with lived experience of diverse cancers (n = 19) and multidisciplinary healthcare professionals (n = 36) in Australia.

RESULTS

Participants identified three key challenges: awareness, access, and financial burden. These informed the identification of three key enablers for better consumer-centred care: patient and provider education/training, care pathway, and recognition of lymphoedema as a chronic disease. The need for a national registry system was identified as a key enabler to quantify the burden of disease to support equitable access to resources and treatment.

CONCLUSION

Cancer survivors at risk of, or experiencing lymphoedema, face significant challenges that could be overcome through initiatives prioritising self-management education and clinician training, navigation, and reimbursement for care.

IMPLICATIONS FOR CANCER SURVIVORS

Lymphoedema risk reduction and management remains a neglected aspect of survivorship care but survivors and healthcare providers identify a number of strategies to improve lymphoedema care that warrant examination.

Preventive effects of progressive resistance training of different intensities on breast cancer-related lymphedema

PURPOSE

Explore the preventive effects of varying intensity progressive resistance exercise on breast cancer-related lymphedema.

METHODS

A total of 114 breast cancer patients who underwent axillary lymph node dissection at Tangshan People's Hospital from January to April 2024 were included. Participants were randomly assigned to three groups: the control group received conventional care; intervention group 1 received conventional care + low-intensity progressive resistance exercise; and intervention group 2 received routine nursing + moderate and high-intensity progressive resistance exercise. Body composition and grip strength were assessed pre-intervention, post-intervention, and at 3 and 6 months follow-up to compare differences among the groups.

RESULTS

(1) Body composition: At post-intervention, 3 and 6 months follow-up, segmental water differences and extracellular water ratios, along with 1- and 5-kHz SFBIA in both intervention groups, were lower than in the control group. Intervention group 2 had a lower extracellular water ratio than group 1 at post-intervention, and at 3 months follow-up, group 2 showed lower water differences and extracellular water ratios than group 1, with slight variations at 6 months (P < 0.001). (2) Grip strength: At post-intervention, 3 months and 6 months follow-up, grip strength in intervention group 1 and intervention group 2 was higher than that in control group, and the difference was statistically significant (P < 0.001).

CONCLUSION

Resistance exercise enhances muscle strength and prevents lymphedema, with moderate-high-intensity exercise proving more effective than low intensity. Adverse events were minimal, suggesting that increasing resistance exercise intensity, while considering participants' conditions, may yield better preventive outcomes.

Risk factors and prediction model of breast cancer-related lymphoedema in a Chinese cancer centre: a prospective cohort study protocol

INTRODUCTION

Lymphoedema is a distressing and long-term complication for breast cancer survivors. However, the reported incidence of lymphoedema varies, and its risk factors remain underexplored. Currently, a well-established risk prediction model is still lacking. This study aims to describe the rationale, objectives, protocol and baseline characteristics of a prospective cohort study focused on examining the incidence and risk factors of breast cancer-related lymphoedema (BCRL), as well as developing a risk prediction model.

METHODS AND ANALYSIS

This study is an ongoing single-centre prospective observational cohort study recruiting 1967 patients with breast cancer scheduled for surgery treatment in northern China between 15 February 2022 and 21 June 2023. Assessments will be conducted presurgery and at 1, 3, 6, 12, 18, 24, 30 and 36 months postsurgery. Bilateral limb circumferences will be measured by patients at home or by researchers at the outpatient clinics during follow-up visits. The diagnosis of lymphoedema is based on a relative limb volume increase of ≥10% from the preoperative assessment. Self-reported symptoms will be assessed to assist in diagnosis. Potential risk factors are classified into innate personal traits, behavioural lifestyle, interpersonal networks, socioeconomic status and macroenvironmental factors, based on health ecology model. Data collection, storage and management were conducted using the online 'H6WORLD' data management platform. Survival analysis using the Kaplan-Meier estimate will determine the incidence of BCRL. Risk factors of BCRL will be analysed using log-rank test and COX-LASSO regression. Traditional COX regression analysis and seven common survival analysis machine learning algorithms (COX, CARST, RSF, GBSM, XGBS, SSVM and SANN) will be employed for model construction and validation.

ETHICS AND DISSEMINATION

The study protocol was approved by the Biomedical Ethics Committee of Peking University (IRB00001052-21124) and the Research Ethics Committee of Tianjin Medical University Cancer Institute and Hospital (bc2023013). The results of this study will be published in peer-reviewed journals and will be presented at several research conferences.

TRIAL REGISTRATION NUMBER

ChiCTR2200057083.

Risk Profiling of Breast Cancer-Related Lymphedema (BCRL) in Patients With Breast Cancer Via Using Body Composition and Tissue Dielectric Constant (TDC) Method: A Cross-Sectional Study

BACKGROUND

Breast Cancer-Related Lymphedema (BCRL) is one of the most prominent long-term side effects of breast cancer (BC) treatment. Although an increased BMI is a well-recognized risk factor for BCRL, there is a lack of knowledge regarding the potential associations between body composition and the risk of BCRL. Therefore, this study aimed to analyze the BCRL risk profiles of surgically operated BC patients via body composition and the Tissue Dielectric Constant (TDC) method, respectively.

METHODS

A total of 72 patients were included. Patients' risk for BCRL was assessed with Moisture MeterD (Delfin, Finland) in 4 different probes each has unique penetration depths from 0.5 (10 mm) to 5.0 (55 mm) at both upper extremities. The body composition was analyzed with Tanita-BC-420 (TANITA, Japan). Comparing the dielectric values of extremities and proportioning to one another as TDC ratio (at-risk side/unaffected side) was used to profile BCRL risk.

RESULTS

TDC values of the thorax reference point were significantly higher in all four probes on the at-risk side (P < .05). TDC ratios in the forearm and Thorax points were significantly correlated with fat mass (r = 0.256, P = .030; r = 0.269, P = .022) as well as with visceral fat rating (VFR) (r = 0.340, P = .003; r = 0.466, P < .001).

CONCLUSION

This study highlights the need for further care and investigation in the assessment and prediction of BCRL by considering body composition. Since the risk reduction of BCRL can be maximized by considering the individual features, we can conclude that patients with higher body fat irrespective of the BMI should be followed up regularly.

Effects of Short-Term Educational Hospitalization with Multidisciplinary Approach for Lymphedema on Limb Circumference and Quality of Life

Background: Lymphedema is an intractable disease requiring lifelong treatment. Daily self-care by the patient is essential; however, establishing care is often difficult. Our hospital offers a short-term educational hospitalization program that involves intensive, multidisciplinary intervention to develop self-care. This study aimed to evaluate the effectiveness of this program. Methods and Results: Among the patients diagnosed with primary or secondary lymphedema who underwent educational hospitalization, 31 cases (33 limbs) were included in this study. The upper extremity lymphedema (UEL) index and lower extremity lymphedema (LEL) index were used for objective evaluation, and the Lymphedema Quality of Life Questionnaire was used for subjective evaluation. The therapeutic effects of educational hospitalization were examined before admission, at discharge, and at 6 months postdischarge. The UEL/LEL index significantly decreased for both the upper and lower limbs after educational hospitalization. In addition, the UEL/LEL index change rate from prehospitalization to 6 months postdischarge was compared between the continued and discontinued exercise groups; the former index showed significantly more improvement than the latter. Comparing the quality of life (QOL) assessments pre- and posthospitalization, statistically significant improvements were observed in all categories, including function, appearance, symptoms, and psychological state. Conclusions: Short-term educational hospitalization led to a sustained reduction in the circumference of lymphedema-affected limbs and an improvement in the QOL. The multidisciplinary approach resulted in improved self-efficacy and established daily self-care.

Role experiences of women with breast cancer as daughters: A qualitative meta-synthesis

Objective

To synthesize qualitative data on the role experiences of women with breast cancer as daughters, and thereby provide inspiration and reference for psychological and social interventions for these patients and their families.

Methods

Six English databases (PubMed, Web of Science, CINAHL, Embase, Cochrane Library, and Joanna Briggs Institute) and four Chinese databases (CNKI, Wanfang, VIP, and CBM) were searched from inception to June 2024 to retrieve qualitative or mixed-methods studies on the role experiences of women with breast cancer as daughters. The Joanna Briggs Institute Critical Appraisal Tool for qualitative research was used to evaluate study quality, and the results were integrated using a meta-aggregation approach.

Results

Eighteen studies were included in this meta-synthesis: 37 findings were extracted and aggregated into 10 categories and three synthesized findings. Synthesized findings focused on negative experiences in the role of daughter; positive experiences in the role of daughter; and support needs in the role of daughter. The confidence of all synthesized findings was moderate.

Conclusions

Emphasis should be placed on the role experiences of women with breast cancer as daughters, and targeted practical assistance and professional support should be provided to promote the stable development of the patient's relationship with their parents and enhance the coping ability of both patients and their families.

Systematic review registration

PROSPERO, CRD42023456567.

The influence of non-cancer-related risk factors on the development of cancer-related lymphedema: a rapid review

Extensive research supports an evidence-base for cancer treatment-related risk factors, including extent of lymph node dissection and use of radiotherapy, as contributing to secondary lymphedema. Additionally, comorbidities, such as higher body mass index, and vascular-related conditions are identified to further augment risk. While social determinants of health (SDOH) and socioeconomic factors are widely regarded as influencing an individual's healthcare outcomes, including cancer risk and survival, these factors have not been explored as risk factors for developing secondary lymphedema. A rapid literature review explored the current evidence for SDOH as risk factors for lymphedema. Studies that were published over the last 10 years and that specifically analyzed social factors as variables associated with lymphedema were included. Studies that only characterized the social determinants of the study population were not included. Forty-nine studies were identified through a rapid literature review, and 13 studies that expressly analyzed social determinants as risk factors for secondary lymphedema were reviewed and extracted. All studies were conducted in patients with breast cancer-related lymphedema. Social risk factors included race, educational level, insurance type, and income level. These are consistent with the socioeconomic inequalities related to cancer survival. SDOH may influence the risk of developing cancer treatment-related health conditions like secondary lymphedema. Research trials studying cancer treatment-related conditions should collect consistent and robust data across social, behavioral, environmental, and economic domains and should analyze these variables to understand their contribution to study endpoints. Risk prediction modeling could be a future pathway to better incorporate social determinants, along with medical and co-morbidity data, to holistically understand lymphedema risk.

Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women

Importance

Higher lymphedema rates after axillary lymph node dissection (ALND) have been found in Black and Hispanic women; however, there is poor correlation between subjective symptoms, quality of life (QOL), and measured lymphedema. Additionally, racial and ethnic differences in QOL have been understudied.

Objective

To evaluate the association of race and ethnicity with long-term QOL in patients with breast cancer treated with ALND.

Design, Setting, and Participants

This cohort study enrolled women aged 18 years and older with breast cancer who underwent unilateral ALND at a tertiary cancer center between November 2016 and March 2020. Preoperatively and at 6-month intervals, arm volume was measured by perometer and QOL was assessed using the Upper Limb Lymphedema-27 (ULL-27) questionnaire, a validated tool for assessing lymphedema that evaluates how arm symptoms affect physical, psychological, and social functioning. Data were analyzed from November 2016 to October 2023.

Exposures

Breast surgery and unilateral ALND in the primary setting or after sentinel lymph node biopsy.

Main Outcomes and Measures

Scores in each domain of the ULL-27 were compared by race and ethnicity. Factors impacting QOL were identified using multivariable regression analyses.

Results

The study included 281 women (median [IQR] age, 48 [41-58] years) with breast cancer who underwent unilateral ALND and had at least 6 months of follow-up. Of these, 30 patients (11%) self-identified as Asian individuals, 57 (20%) as Black individuals, 23 (8%) as Hispanic individuals, and 162 (58%) as White individuals; 9 individuals (3%) who did not identify as part of a particular group or who were missing race and ethnicity data were categorized as having unknown race and ethnicity. Median (IQR) follow-up was 2.97 (1.96-3.67) years. The overall 2-year lymphedema rate was 20% and was higher among Black (31%) and Hispanic (27%) women compared with Asian (15%) and White (17%) women (P = .04). Subjective arm swelling was more common among Asian (57%), Black (70%), and Hispanic (87%) women than White (44%) women (P < .001), and lower physical QOL scores were reported by racial and ethnic minority women at nearly every follow-up. For example, at 24 months, median QOL scores were 87, 79, and 80 for Asian, Black, and Hispanic women compared with 92 for White women (P = .003). On multivariable analysis, Asian race (β = -5.7; 95% CI, -9.5 to -1.8), Hispanic ethnicity (β = -10.0; 95% CI, -15.0 to -5.2), and having Medicaid (β = -5.4; 95% CI, -9.2 to -1.7) or Medicare insurance (β = -6.9; 95% CI, -10.0 to -3.4) were independently associated with worse physical QOL (all P < .001).

Conclusions and Relevance

Findings of this cohort study suggest that Asian, Black, and Hispanic women experience more subjective arm swelling after unilateral ALND for breast cancer compared with White women. Black and Hispanic women had higher rates of objective lymphedema than their White counterparts. Both minority status and public medical insurance were associated with worse physical QOL. Understanding disparities in QOL after ALND is an unmet need and may enable targeted interventions to improve QOL for these patients.

Interventions to Mitigate Financial Toxicity in Adult Patients with Cancer in the United States: A Scoping Review

Financial toxicity adversely affects quality of life and treatment outcomes for patients with cancer. This scoping review examined interventions aimed at mitigating financial toxicity in adult patients with cancer and their effectiveness. We utilized five bibliographical databases to identify studies that met our inclusion criteria. The review included studies conducted among adult patients with cancer in the United States and published in English between January 2011 to March 2023. The review identified eight studies that met the inclusion criteria. Each of the studies discussed the implementation of interventions at the patient/provider and/or health system level. Collectively, the findings from this scoping review highlight both the limited number of published studies that are aimed at mitigating financial toxicity and the need to create and assess interventions that directly impact financial toxicity in demographically diverse populations of adult patients with cancer.